IVCD stands for intraventricular conduction delay, a condition where electrical signals travel slower than normal through the lower chambers of your heart. It shows up on an electrocardiogram (ECG or EKG) as a widened QRS complex, the spike on the tracing that represents each heartbeat’s electrical pulse moving through the ventricles. IVCD is found in roughly 0.6% to 1.3% of the general population, depending on how broadly it’s defined.
How the Heart’s Electrical System Works
Your heart has a built-in wiring system. Each beat starts with an electrical impulse at the top of the heart, which travels down through a network of specialized fibers called the bundle branches and the Purkinje network. These fibers split into a right branch (serving the right ventricle) and a left branch (serving the left ventricle), ensuring both chambers contract in a coordinated, synchronized squeeze. When signals move through this system without delay, the QRS complex on an ECG is narrow and crisp, typically lasting under 110 milliseconds.
IVCD means something is slowing those signals down. The QRS complex stretches to 110 milliseconds or longer, indicating the ventricles aren’t activating as quickly or as evenly as they should. This can lead to a less efficient heartbeat because parts of the heart muscle contract out of sync with each other.
Types of Conduction Delays
IVCD is an umbrella term that covers several patterns, each reflecting where in the wiring system the slowdown occurs:
- Right bundle branch block (RBBB): The signal to the right ventricle is delayed. This is relatively common and often benign in people without other heart disease.
- Left bundle branch block (LBBB): The signal to the left ventricle is delayed. Because the left ventricle does most of the heavy lifting for pumping blood to the body, LBBB tends to carry more clinical significance.
- Incomplete bundle branch blocks: Partial delays in either branch that widen the QRS complex but don’t meet the full criteria for a complete block.
- Non-specific IVCD (NSIVCD or NIVCD): The QRS is prolonged to 110 ms or more, but the pattern on the ECG doesn’t fit neatly into the criteria for any specific bundle branch block. This category reflects a more diffuse or scattered slowing of electrical conduction.
Non-specific IVCD is particularly worth paying attention to. Research suggests the electrical activation in NSIVCD starts relatively normally through the Purkinje network but then slows down when it hits areas of scarred or damaged heart tissue. This uneven activation pattern is what makes it potentially more dangerous than a straightforward bundle branch block.
What Causes It
IVCD can result from structural damage to the heart, metabolic problems, or medication effects. The most common underlying causes include coronary artery disease (where reduced blood flow damages the conduction fibers), cardiomyopathy (disease of the heart muscle itself), heart valve disease, and prior heart attacks that leave scar tissue in the path of electrical signals. Heart surgery and infections like Lyme disease can also disrupt conduction.
Several common medications slow electrical conduction as a side effect. Beta blockers, calcium channel blockers, and digitalis can all delay signal transmission through the heart. In many cases, the conduction delay resolves or improves if the medication is adjusted. Electrolyte imbalances, particularly abnormal potassium or calcium levels, are another reversible cause.
In some people, especially younger individuals with an incomplete right bundle branch block, no underlying cause is ever found. The finding is incidental and may not indicate any heart disease at all.
Symptoms and How It’s Found
Most people with IVCD have no symptoms from the conduction delay itself. It’s typically discovered during a routine ECG or when someone is being evaluated for an unrelated concern. The significance of the finding varies widely. For some, it’s completely benign. For others, it signals underlying heart disease that needs further evaluation.
When symptoms do occur, they’re usually caused by the underlying condition rather than the conduction delay alone. If the delay is severe enough to reduce how effectively the heart pumps, you might notice fatigue, shortness of breath, lightheadedness, or reduced exercise tolerance. These symptoms overlap heavily with heart failure, which is one of the conditions most closely linked to IVCD.
Why It Matters for Long-Term Health
IVCD is more than just an ECG curiosity. A large Finnish study that followed nearly 11,000 middle-aged adults for 30 years found that IVCD (defined as QRS of 110 ms or longer without a specific bundle branch block pattern) was associated with a twofold or greater increase in all-cause mortality, cardiac mortality, and sudden arrhythmic death.
A separate study of patients with acute coronary syndromes found even starker differences over 12 years of follow-up. Cardiac mortality was 19.6% among patients with no conduction delay, compared to 33.2% for those with RBBB, 46.2% for LBBB, and 57.0% for non-specific IVCD. After adjusting for age and other heart conditions, all three types of IVCD remained independently associated with higher cardiac death rates. Non-specific IVCD carried the highest risk, with roughly 2.7 times the rate of cardiac mortality compared to patients with normal conduction.
The proposed explanations for this elevated risk center on two mechanisms: heart failure and dangerous heart rhythms. The uneven, sluggish activation of the ventricles reduces pumping efficiency over time, and the same scarred or diseased tissue causing the delay can also serve as a trigger point for life-threatening arrhythmias.
What Happens After Diagnosis
If IVCD appears on your ECG, the next step is usually figuring out why it’s there. Your doctor will look at the overall ECG pattern, your medical history, and your symptoms to decide how aggressively to investigate. An echocardiogram (ultrasound of the heart) is the most common follow-up test, since it can reveal whether the heart muscle is weakened, whether the chambers are enlarged, and whether the walls are contracting in sync.
If the echocardiogram shows reduced heart function, additional testing may follow, including stress testing or cardiac imaging to check for blocked arteries. If no structural problems are found and you have no symptoms, ongoing monitoring with periodic ECGs may be all that’s needed.
Treatment Options
There’s no treatment for the conduction delay itself. Management focuses on the underlying cause. If a medication is slowing conduction, adjusting the dose or switching drugs may help. If coronary artery disease is the culprit, treatment targets blood flow restoration. If heart failure is present, standard heart failure therapies form the foundation.
For patients who have both IVCD and significant heart failure, cardiac resynchronization therapy (CRT) may be an option. CRT involves implanting a specialized pacemaker that sends coordinated electrical pulses to both ventricles, essentially overriding the faulty wiring to restore a more synchronized contraction. Guidelines from the American College of Cardiology, the American Heart Association, and European societies recommend considering CRT for patients with a non-LBBB conduction pattern when the QRS duration is 150 ms or longer and the heart’s pumping strength (ejection fraction) is 35% or below, provided symptoms persist despite medication. For QRS durations between 120 and 149 ms with a non-LBBB pattern, the evidence of benefit is weaker, and CRT is generally reserved for patients with the most severe symptoms.
The benefit of CRT is most firmly established in patients with LBBB. For non-specific IVCD patterns, the response to CRT is less predictable, and the decision to implant a device involves careful weighing of potential benefit against procedural risks.